Posted on 03/03/2010 in Medical Company Financials Corin Group has experienced a year-on-year increase in sales in 2009 thanks to the strength of its business in international territories.
According to the medical technology firm's latest annual financial report, sales for 2009 came to a total of 40.6 million pounds, a two per cent increase on 2008 figures.
It stated that this was primarily due to rising sales of many of its prosthetic technology products in areas outside the US, with hip sales in international regions rising by 18 per cent year-on-year.
Peter Huntley, Corin's chief executive, said that these results were due to the effect of the company's new business strategy, which he stated will offer further benefits in the coming months.
He said: "The financial impact of our strategy should become evident as the year progresses, particularly from the Trinity acetabular cup roll-out and from the benefits of offering a full continuum-of-care in the primary hip market."
Last month, the company hosted a conference on ankle replacement technology in Bristol in order to allow industry experts to share and discuss best practice.Other news stories from 03/03/2010
Read more in the Zenopa News Archive
How this news is generated
|
